- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cardinal Health's Naveen Mansukhani Details How Lowering Costs Is a Multi-Department Effort
Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health, talks about how the responsibility for saving costs does not just fall on one department or person, but is collaborative and requires strategy.
Reducing costs falls on multiple health care departments, and the help of data, analytics, and specialty pharmacy strategies can ensure that cost reduction is successful, says Naveen Mansukhani, director of operations and account management of Retail Pharmacy Services at Cardinal Health.
Transcript
What strategies are health systems employing to combat the increasing costs of specialty drugs within their specialty pharmacy programs?
It's really about employing a collaborative approach. It's not just a pharmacy problem of controlling costs. It's also patient navigators, the pharmacy department, the billing department, ensuring that things are getting built properly before it's administered to a patient, where it ends up being a cost to the hospital.
How are health systems leveraging data and analytics to identify cost-saving opportunities and make informed decisions regarding specialty drug pricing and procurement?
This iswhere the importance of a specialty GPO [group purchasing organizations] comes into play. Specialty GPOs can help with these data analytics and ensure that the hospitals are buying the best possible drug at the least possible cost.
Are there any best practices or success stories of health system specialty pharmacy strategies that have effectively tackled the challenge of escalating specialty drug costs?
There's many hospitals that have employed strategies that, really from a retail perspective, of getting specialty drugs into the community. So, from hospital into community of ordering these drugs, and now they become a revenue to the hospital versus just simply a cost. That's where a specialty pharmacy strategy really makes sense, and where hospitals are finding success. It also helps with the patient end to end approach where the hospital is able to work with patients on the outside when they become outpatients. It improves compliance, It improves outcomes, and it controls overall health care costs.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Sleep Patterns, Predictors, and Pharmacologic Interventions in the ICU
May 19th 2025Research presented at the American Thoracic Society (ATS) 2025 International Conference used FDA-approved tools to see how sleep can impact other parts of recovery for patients in the intensive care unit (ICU).
Read More
The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD
May 17th 2025Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't replaced stem cell transplantation, Harsh Parmar, MD, of Hackensack University Medical Center, explains.
Read More
Specialty Drug Users to Gain Relief Under Medicare Reforms
May 16th 2025A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often represent a significant cost burden for Medicare Part D beneficiaries and which were selected for 2026 drug price negotiation under the Inflation Reduction Act.
Read More
